Drug profile · INN
fosinopril
MONACE 10
fosinopril (MONACE 10) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — fosinopril
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
fosinopril (MONACE 10) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN fosinopril
Brand MONACE 10
Mechanism Angiotensin-converting enzyme inhibitor
Originator Alphapharm Pty Ltd
Mechanism of action
Angiotensin-converting enzyme inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is fosinopril?
fosinopril (MONACE 10) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for fosinopril?
MONACE 10 is a marketed brand name for fosinopril. Check FDA Drugs@FDA for the current US label holder and prescribing information.